Angiotensin II formation in the human heart: An ACE or non-ACE-mediated pathway?

Annals of Medicine

Volumn 30, Issue SUPPL. 1, 1998, Pages 9-13

  Kokkonen, Jorma O ^a   Saarinen, Juhani ^a   Kovanen, Petri T ^a  

^a WIHURI RESEARCH INSTITUTE   (Finland)

Author keywords

Angiotensin; Angiotensin converting enzyme; Chymase; Heart failure; Interstitium; Mast cell

Indexed keywords

ANGIOTENSIN; CHYMASE; CHYMOTRYPSIN; DIPEPTIDYL CARBOXYPEPTIDASE; PROTEINASE INHIBITOR; PROTEOGLYCAN; SERINE PROTEINASE;

ANIMAL TISSUE; CONFERENCE PAPER; HEART; HEART FAILURE; HUMAN; HUMAN TISSUE; INTERSTITIAL FLUID; INTERSTITIUM; MAST CELL; NONHUMAN; PRIORITY JOURNAL;

ANGIOTENSIN II; ANIMALS; HEART FAILURE, CONGESTIVE; HUMANS; MYOCARDIUM; PEPTIDYL-DIPEPTIDASE A; RESEARCH DESIGN; SENSITIVITY AND SPECIFICITY;

EID: 0031690160     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. Baker KM, Aceto JF. Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells. Am J Physiol 1990; 259: H610-4.
2. Brilla CG, Pick R, Tan LB, Janicki JS, Weber KT. Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res 1990; 67: 1355-64.
3. Brilla CG, Zhou G, Matsubara L, Weber KT. Collagen metabolism in cultured adult rat cardiac fibroblasts. Response to angiotensin II and aldosterone. J Mol Cell Cardiol 1994; 26: 809-20.
4. Lindpaintner K, Jin MW, Niedermaier N, Wilhelm MJ, Ganten D. Cardiac angiotensinogen and its local activation in isolated perfused beating heart. Circ Res 1990; 67: 564-73.
5. Dzau VJ, Re R. Tissue angiotensin system in cardiovascular medicine. A paradigm shift? Circulation 1994; 89: 493-8.
6. Urata H, Healy B, Stewart RW, Bumbus FM, Husain A. Angiotensin II-forming pathways in normal and failing hearts. Circ Res 1990; 66: 883-90.
7. Urata H, Kinoshita A, Misono KS, Bumbus FM, Husain A. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem 1990; 265: 22348-57.
8. Hoit BD, Shao Y, Kinoshita A, Gabel M, Husain A, Walsh RA. Effects of angiotensin II generated by an angiotensin-converting enzyme-independent pathway on the left ventricular performance in the conscious baboon. J Clin Invest 1995; 95: 1519-27.
9. Katwa LC, Ratajska A, Cleutjens JPM, et al. Angiotensin converting enzyme and kininase-II-like activities in cultured valvular interstitial cells of the rat heart. Cardiovasc Res 1995; 29: 57-64.
10. Kokkonen JO, Saarinen J, Kovanen PT. Regulation of local angiotensin II formation in the human heart in the presence of interstitial fluid. Inhibition of chymase by protease inhibitors of interstitial fluid and of angiotensin-converting enzyme by Ang-(1-9) formed by heart carboxypeptidase A-like activity. Circulation 1997; 95: 1455-63.
11. Urata H, Boehm KD, Philip A, et al. Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart. J Clin Invest 1993; 91: 1269-81.
12. Husain A. The chymase-angiotensin system in humans. J Hypertens 1993; 11: 1155-9.
13. Zisman LS, Abraham WT, Meixell GE, et al. Angiotensin formation in the intact human heart. Predominance of the angiotensin-converting enzyme pathway. J Clin Invest 1995; 96: 1490-8.
14. Balcells E, Meng QC, Hageman GR, Palmer RW, Durand JN, Dell'Italia LJ. Angiotensin II formation in dog heart is mediated by different pathways in vivo and in vitro. Am J Physiol 1996; 271: H417-21.
15. Vermeer BJ, Reman FC, van Gent CM. The determination of lipids and proteins in suction blister fluid. J Invest Dermatol 1979; 73: 303-5.
16. 1-antitrypsin and serum proteins in suction blister fluid; effect of local glucocorticosteroid treatment. Arch Dermatol Res 1986; 278: 497-9.
17. Kiistala U, Mustakallio K. Dermo-epidermal separation with suction. Electron microscopic and histochemical study of initial events of blistering on human skin. J Invest Dermatol 1967; 48: 466-77.
18. Volden G, Thorsrud AK, Bjørnson I, Jellum E. Biochemical composition of suction blister fluid determined by high resolution multicomponent analysis (capillary gas chromatography-mass spectrometry and two-dimensional electrophoresis). J Invest Dermatol 1980; 75: 421-4.
19. Dabbagh AJ, Frei B. Human suction blister interstitial fluid prevents metal ion-dependent oxidation of low density lipoproteins by macrophages and in cell-free systems. J Clin Invest 1995; 96: 1958-66.
20. Schecter NM, Sprows JL, Schoenberger OL, Lazarus GS, Cooperman BS, Rubin H. Inhibition of human skin chymotrypsin-like proteinase chymase with plasma proteinase inhibitors. J Biol Chem 1989; 264: 21308-15.
21. Pejler G, Berg L. Regulation of rat mast cell protease 1 activity. Protease inhibition is prevented by heparin proteoglycan. Eur J Biochem 1995; 233: 192-9.
22. Lindstedt L, Lee M, Castro GR, Fruchart J-C, Kovanen PT. Chymase in exocytosed rat mast cell granules effectively proteolyzes apolipoprotein A I-containing lipoproteins, so reducing the cholesterol efflux-inducing ability of serum and aortic intimai fluid. J Clin Invest 1996; 97: 2174-82.